Medicare now approves weight-loss drugs for people with heart problems
There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]
Why it’s so hard to get your weight-loss drugs
On February 2nd, 2024, the venerable New York Times published an article titled “Six Reasons Why It’s So Hard to Get Your Weight-Loss Drugs”. There were few surprises for us in what the NYT wrote because we have been hearing many of the same complaints from new customers who have been struggling to fill their […]
Changes in insurance coverage for Ozempic
There’s been a rapid revolution in how U.S. insurers cover (or don’t cover) the cost of the newer type 2 diabetes medications like Ozempic, Wegovy, and Mounjaro. In this short article, we offer a general overview of the highly volatile situation concerning insurance coverage for these medicines. We aren’t trying to predict what could be […]
Combating GLP-1 hair loss with Phyllotex
Losing weight can truly feel like a victory. But along with the celebratory feeling of weight loss many people experience while using new GPL1 weight loss drugs like Ozempic – there can be another unwelcome side effect: loss of hair health. While the exact connection is still being investigated, many are looking for immediate solutions […]
Weaning off weight-loss meds?
A number of our customers have asked us for advice about their options regarding their desire to stop using the new weight-loss drugs that have taken the world by storm. Primarily, people want to know how to minimize any possible consequences of weaning off Wegovy and its earlier version Ozempic. These new drugs brought improved […]
What’s the difference between Ozempic and Mounjaro?
Ozempic / Wegovy and Mounjaro / Zepbound (and their base components semaglutide and tirzepatide) are currently the “hottest” medications on the market. You don’t have to be a doctor or pharmacist to get to this conclusion; the stock market tells the story. Sales of Ozempic / Wegovy (based on semaglutide) from Novo Nordisk and Mounjaro / […]
What We Know About the Obesity Epidemic
Over the last 50 years, global obesity rates have reached such alarming levels that words like “obesity epidemic” and even “pandemic” are being used by respected journals and international bodies like the World Health Organization (WHO) as they try to raise awareness in the public and healthcare sectors. According to the World Health Organization, there […]
Mounjaro is hot news, for good reason
I recently conducted a very informal survey with our staff here at IsraelPharm and asked them a simple question: what healthcare subject are our customers most interested in? 8 out of 10 responded quickly and unequivocally: losing weight, and the medications that can help. What was once a peripheral sideshow of healthcare has become one […]
If it brings such great benefits, why do people stop taking Ozempic?
A natural question has arisen. “If they have such great benefits and are so popular, why do people stop taking Ozempic, Mounjaro and Wegovy?” Ozempic and Mounjaro are considered “wonder drugs” out of all the treatments for type 2 diabetes, which have brought significant benefits to millions of people worldwide who develop type 2 diabetes and caused […]
Good News about Semaglutide Side Effects
Examining the Semaglutide Treatment Effect in People (STEP 1) trials for weight loss provides answers to many questions about this subject. With many companies in the pharmaceutical industry bustling to secure their place in what may well become a prominent drug market segment, understanding these trials becomes vital. The trial was a randomized, double-blind, […]
